Vectus Biosystems Limited (ASX:VBS)
Australia · Delayed Price · Currency is AUD 0.1500
0.00 (0.00%)
Aug 26, 2026, 4:10 PM AEST
Vectus Biosystems Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 0.33 | 0.25 | 0.81 | 2.95 | 1.28 | 5.78 |
Cash & Short-Term Investments | 0.33 | 0.25 | 0.81 | 2.95 | 1.28 | 5.78 |
Cash Growth | -59.19% | -68.97% | -72.59% | 130.30% | -77.82% | 115.18% |
Other Receivables | 0.01 | 0.44 | 0.98 | 1.43 | 2.32 | 0.98 |
Receivables | 0.01 | 0.44 | 0.98 | 1.43 | 2.32 | 0.98 |
Inventory | - | 0 | 0 | 0 | 0 | - |
Prepaid Expenses | 0.04 | 0.09 | 0.06 | 0.07 | 0.13 | 0.15 |
Other Current Assets | 0.07 | - | - | - | - | - |
Total Current Assets | 0.46 | 0.78 | 1.84 | 4.46 | 3.73 | 6.91 |
Property, Plant & Equipment | 0 | 0 | 0.18 | 0.17 | 0.21 | 0.07 |
Total Assets | 0.46 | 0.78 | 2.03 | 4.63 | 3.94 | 6.98 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Accounts Payable | 0.52 | 0.53 | 0.19 | 0.22 | 0.12 | 0.33 |
Accrued Expenses | 0.28 | 0.3 | 0.29 | 0.54 | 1.3 | 0.84 |
Short-Term Debt | - | - | - | - | 0.44 | 0.44 |
Current Portion of Long-Term Debt | - | - | - | - | 5.45 | - |
Current Portion of Leases | - | - | 0.03 | 0.04 | 0.06 | 0.02 |
Other Current Liabilities | - | 0 | 0.03 | 0.03 | 0.03 | 0.02 |
Total Current Liabilities | 0.8 | 0.84 | 0.53 | 0.83 | 7.4 | 1.66 |
Long-Term Debt | 0.47 | 0.2 | - | - | - | 7.19 |
Long-Term Leases | - | - | - | 0.03 | 0.07 | 0.02 |
Other Long-Term Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 1.27 | 1.04 | 0.54 | 0.86 | 7.47 | 8.87 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Common Stock | 38.37 | 38.37 | 38.37 | 38.35 | 27.3 | 24.83 |
Retained Earnings | -40.06 | -39.5 | -37.73 | -35.39 | -32.18 | -28.19 |
Comprehensive Income & Other | 0.88 | 0.88 | 0.84 | 0.8 | 1.35 | 1.47 |
Shareholders' Equity | -0.81 | -0.26 | 1.49 | 3.77 | -3.53 | -1.89 |
Total Liabilities & Equity | 0.46 | 0.78 | 2.03 | 4.63 | 3.94 | 6.98 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Total Debt | 0.47 | 0.2 | 0.03 | 0.07 | 6.02 | 7.67 |
Net Cash (Debt) | -0.14 | 0.05 | 0.78 | 2.88 | -4.73 | -1.89 |
Net Cash Growth | - | -93.46% | -72.92% | - | - | - |
Net Cash Per Share | -0.00 | 0.00 | 0.01 | 0.06 | -0.14 | -0.07 |
Filing Date Shares Outstanding | 53.34 | 53.28 | 53.21 | 53.19 | 37.03 | 31.66 |
Total Common Shares Outstanding | 53.34 | 53.28 | 53.21 | 53.19 | 36.26 | 31.66 |
Working Capital | -0.34 | -0.06 | 1.31 | 3.62 | -3.67 | 5.25 |
Book Value Per Share | -0.02 | -0.00 | 0.03 | 0.07 | -0.10 | -0.06 |
Tangible Book Value | -0.81 | -0.26 | 1.49 | 3.77 | -3.53 | -1.89 |
Tangible Book Value Per Share | -0.02 | -0.00 | 0.03 | 0.07 | -0.10 | -0.06 |
Machinery | - | 0.09 | 0.96 | 0.9 | 0.9 | 0.74 |